Prescient Healthcare Group names Debasish Talukdar global head of advisory

Talukdar will lead the firm's advisory practice, VantageRx.

10 myths about millennials and their healthcare habits

More has been written about millennials — and their healthcare habits — than about any other generation. Here, Gen Y marketers explain why most of ...

MM&M's Data Week: Demystifying one of pharma's biggest pain points

MM&M's Data Week: Demystifying one of pharma's biggest pain points

It was at an MM&M event back in late 2013 that I got my first glimpse of how this industry feels about big data.

Get to know your data scientist: Four data aces share their knowledge

Get to know your data scientist: Four data aces share their knowledge

Four data aces share their backgrounds, inspirations, and guiding philosophies

Big Predictions: Agency gurus on the future of data in the industry

Big Predictions: Agency gurus on the future of data in the industry

We asked some of the agency world's sharpest data people to answer a pair of questions about the future of data in and around pharma marketing. Here's what they had to say.

High five: How these companies are leveraging data to engage A-list HCPs

High five: How these companies are leveraging data to engage A-list HCPs

In the past, pharma hasn't used data effectively to engage its A-list HCPs. Five companies hope to change that.

Real-world evidence: It's finally having its moment

Real-world evidence: It's finally having its moment

Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled

Five things for pharma marketers to know: Tuesday, February 20, 2018

Five things for pharma marketers to know: Tuesday, February 20, 2018

Gilead wins reversal of $2.5 billion payment order; Aimmune Therapeutics' peanut allergy therapy shows promise; AstraZeneca wins FDA approval on key cancer drug.

Five things for pharma marketers to know: Friday, February 16, 2018

Five things for pharma marketers to know: Friday, February 16, 2018

Roche to acquire Flatiron Health for $1.9B; FDA considers allowing pre-symptom Alzheimer's drug tests; Marijuana producer branches into pharma.

Havas Formula named PR AOR for Colorado Center for Reproductive Medicine

Havas Formula named PR AOR for Colorado Center for Reproductive Medicine

The agency began working with the national reproductive center this month.

Five things for pharma marketers to know: Thursday, February 15, 2018

Five things for pharma marketers to know: Thursday, February 15, 2018

CMS forecasts prescription drug spending to hit $5.7T by 2026; Ipsen predicts cancer drug shopping spree; Omnicom numbers miss estimates on revenue.

National Psoriasis Foundation partners with Remedy Health Media

National Psoriasis Foundation partners with Remedy Health Media

The two organizations will partner on content including personal stories and expert advice.

Interpublic Group's net income drops 4.8% but shares surge on strong Q4

Interpublic Group's net income drops 4.8% but shares surge on strong Q4

In 2017, Interpublic reported a net income of $579 million, down 4.8% from the previous year.

Five things for pharma marketers to know: Wednesday, February 14, 2018

Five things for pharma marketers to know: Wednesday, February 14, 2018

IPG 2017 net income drops; Bristol-Myers Squibb inks $1.85 billion deal with Nektar on cancer drug; Merck halts final-stage Alzheimer's drug.

McCann Health hires first global medical director

McCann Health hires first global medical director

Daniel Carucci is joining the Interpublic Group firm full-time after serving as a consultant and in roles with the U.N. Foundation and the U.S. Navy.

Sanofi revamps web presence as part of Empowering Life campaign

Sanofi revamps web presence as part of Empowering Life campaign

The company is also looking to better combine its web and social media presence.

Medtronic hires Gregory Zimprich as financial comms director

Medtronic hires Gregory Zimprich as financial comms director

Zimprich joins from Honeywell, where he led global business communications.

Five things for pharma marketers to know: Tuesday, February 13, 2018

Five things for pharma marketers to know: Tuesday, February 13, 2018

Amazon moves into medical supply market; Big Pharma gets a tax cut; Former Celgene CEO plans Senate run.

Infographic | Highlighting top healthcare trends

Infographic | Highlighting top healthcare trends

There was so much bigger-picture coverage of pharma and healthcare in 2017 - pricing, Affordable Care Act reform and repeal - that it was easy to lose sight of everything else. PwC's Health Research Institute has used its annual look-ahead report to spotlight a handful of undercover trends.

Purdue Pharma stops marketing opioids to doctors

Purdue Pharma stops marketing opioids to doctors

The pharma company manufactures the well-known opioid OxyContin.

Study: Only one-quarter of clinicians comfortable with value-based payment program

Study: Only one-quarter of clinicians comfortable with value-based payment program

Healthcare providers may understand its importance, but across the board not many are ready to meet the requirements of the program QPP, according to a study.

Payers: High-deductible health plans don't drive positive consumer behavior

Payers: High-deductible health plans don't drive positive consumer behavior

As the evidence mounts that high-deductibles don't cause patients to shop or save for healthcare, payers are taking note.